Cerebellar stimulation for the treatment of dystonia: preclinical studies
小脑刺激治疗肌张力障碍:临床前研究
基本信息
- 批准号:8458057
- 负责人:
- 金额:$ 18.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-15 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAffectAnimal ExperimentsAnimal ModelAnimalsAutopsyBasal GangliaBotulinum ToxinsBrainCase StudyCerebellar DiseasesCerebellumCerebral PalsyCervical DystoniaCervix NeoplasmsClinical ResearchDeep Brain StimulationDiseaseDyskinetic syndromeDystoniaDystonic DisorderElectric StimulationEpilepsyFOS geneFrequenciesFunctional ImagingGlobus PallidusGoalsHumanImageInjection of therapeutic agentLinkLocationMapsMeasuresModelingMovementMovement DisordersMusMuscleMuscle ContractionPatientsPharmaceutical PreparationsPhysiologic pulsePostureRattusReporterReportingSecondary DystoniaSignal TransductionSmooth MuscleTestingWidtheffective therapyexperiencemotor disordermouse modelnovelnovel therapeuticspalliativepre-clinicalpreclinical studysmall moleculesuccesstreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Dystonia is characterized by excessive involuntary muscle contractions that cause abnormal postures and twisting movements. Current treatments for dystonia are largely unsatisfactory or palliative. Small molecule drugs are ineffective in most patients. Botulinum toxin is effective but requires injection into affected muscles, limiting its ue to the treatment of dystonias that affect a small number of muscles. Deep brain stimulation (DBS) of the internal globus pallidus is another treatment option. Some patients, particularly those suffering from primary generalized dystonia experience tremendous benefits from pallidal DBS. However, many other patients, particularly those with secondary dystonias, experience little or no improvement, demonstrating a need for the identification and exploration of new treatment targets. Strong evidence implicates cerebellar abnormalities in dystonia and supports the idea that electrical stimulation of the cerebellum is an effective treatment for dystonia. Autopsy studies established a link between cervical dystonia and tumors of the cerebellum. Further, abnormal activity of the cerebellum is observed in many different forms of dystonia additionally, some cerebral palsy patients, who also often suffer from dystonia in addition to spasticity, have experienced improvement after cerebellar electrical stimulation. However, there are currently no studies examining the use of cerebellar stimulation in dystonia per se. Animal studies demonstrate that cerebellar abnormalities can cause dystonia. Abnormal cerebellar activity is observed in mouse and rat models of dystonia. In rat and mouse models, ablation of the cerebellum ameliorates dystonia. The effects of cerebellar stimulation have not yet been explored in animal models to test the idea that dystonia can be ameliorated using the non-ablative approach of electrical stimulation to interrupt abnormal signaling. Although cerebellar stimulation has been used in humans for decades, the use of cerebellar stimulation for the treatment of dystonia is surprisingly limited despite the strong evidence linking cerebellar dysfunction to dystonia in both human and animal studies. This proposal will systematically examine cerebellar stimulation for the treatment of dystonia in mouse models as preclinical proof-of-concept. The specific aims of this proposal are: Aim 1. To determine parameters of cerebellar stimulation that ameliorates dystonia. The effects of methodically varying stimulation parameters, including location, frequency, and amplitude and pulse width on dystonic and baseline activity are assessed in alert unrestrained mouse models of dystonia. Aim 2. to map the anatomical extent of stimulation. Because c-fos expression is routinely used to map electrical stimulation in brain, we will use the fos reporter TetTag mice to map extent of cerebellar stimulation. The success of this proposal will provide preclinical evidence to support an exploratory clinical study in humans for the use of cerebellar stimulation as a treatment for dystonia.
描述(由申请人提供):肌张力障碍的特征是过度的不自主肌肉收缩,导致异常姿势和扭转运动。目前针对肌张力障碍的治疗在很大程度上不令人满意或姑息。小分子药物对大多数患者无效。肉毒杆菌毒素是有效的,但需要注射到受影响的肌肉,限制了它的使用影响少数肌肉肌张力障碍的治疗。深部脑刺激(DBS)的内部苍白球是另一种治疗选择。一些患者,特别是那些患有原发性全身性肌张力障碍的患者,从苍白球DBS中获得了巨大的益处。然而,许多其他患者,特别是那些继发性肌张力障碍,经验很少或没有改善,表明需要识别和探索新的治疗目标。强有力的证据表明小脑异常与肌张力障碍有关,并支持电刺激小脑是治疗肌张力障碍的有效方法。尸检研究证实了颈部肌张力障碍和小脑肿瘤之间的联系。此外,在许多不同形式的肌张力障碍中观察到小脑的异常活动。此外,除了痉挛状态之外,还经常患有肌张力障碍的一些脑瘫患者在小脑电刺激后经历了改善。然而,目前还没有研究检查使用小脑刺激肌张力障碍本身。动物研究表明,小脑异常可导致肌张力障碍。在肌张力障碍的小鼠和大鼠模型中观察到异常小脑活动。在大鼠和小鼠模型中,小脑消融可改善肌张力障碍。小脑刺激的作用尚未在动物模型中探索,以测试使用电刺激的非消融方法中断异常信号传导可以改善肌张力障碍的想法。尽管小脑刺激已经在人类中使用了几十年,但是尽管在人类和动物研究中有强有力的证据将小脑功能障碍与肌张力障碍联系起来,但是使用小脑刺激治疗肌张力障碍令人惊讶地有限。该提案将系统地检查小脑刺激用于治疗小鼠模型中的肌张力障碍,作为临床前概念验证。本提案的具体目标是:目标1。确定小脑刺激改善肌张力障碍的参数。在肌张力障碍的警觉无限制小鼠模型中评估了系统地改变刺激参数(包括位置、频率和振幅以及脉冲宽度)对肌张力障碍和基线活动的影响。目标2.来绘制刺激的解剖学范围。因为c-fos表达通常用于绘制脑中的电刺激,所以我们将使用fos报告基因TetTag小鼠来绘制小脑刺激的程度。该提案的成功将提供临床前证据,以支持在人类中使用小脑刺激作为肌张力障碍治疗的探索性临床研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLEN J. HESS其他文献
ELLEN J. HESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLEN J. HESS', 18)}}的其他基金
Neuronal Mechanisms underlying sex differences in dystonia
肌张力障碍性别差异背后的神经机制
- 批准号:
10701752 - 财政年份:2022
- 资助金额:
$ 18.82万 - 项目类别:
Neuronal Mechanisms underlying sex differences in dystonia
肌张力障碍性别差异背后的神经机制
- 批准号:
10518475 - 财政年份:2022
- 资助金额:
$ 18.82万 - 项目类别:
Neuronal Mechanisms underlying sex differences in dystonia
肌张力障碍性别差异背后的神经机制
- 批准号:
10784385 - 财政年份:2022
- 资助金额:
$ 18.82万 - 项目类别:
Striatal cell-type specific molecular adaptations in a mouse model of dystonia
肌张力障碍小鼠模型中纹状体细胞类型特异性分子适应
- 批准号:
10057917 - 财政年份:2020
- 资助金额:
$ 18.82万 - 项目类别:
Dopamine neurotransmission in a model of DOPA-responsive dystonia
多巴反应性肌张力障碍模型中的多巴胺神经传递
- 批准号:
9481589 - 财政年份:2017
- 资助金额:
$ 18.82万 - 项目类别:
Dopamine neurotransmission in a model of DOPA-responsive dystonia
多巴反应性肌张力障碍模型中的多巴胺神经传递
- 批准号:
9203641 - 财政年份:2015
- 资助金额:
$ 18.82万 - 项目类别:
Dopamine neurotransmission in a model of DOPA-responsive dystonia
多巴反应性肌张力障碍模型中的多巴胺神经传递
- 批准号:
8887950 - 财政年份:2015
- 资助金额:
$ 18.82万 - 项目类别:
Cerebellar stimulation for the treatment of dystonia: preclinical studies
小脑刺激治疗肌张力障碍:临床前研究
- 批准号:
8269318 - 财政年份:2012
- 资助金额:
$ 18.82万 - 项目类别:
Generation of a mouse model of L-DOPA-responsive dystonia (DRD)
L-DOPA 反应性肌张力障碍 (DRD) 小鼠模型的生成
- 批准号:
7765651 - 财政年份:2007
- 资助金额:
$ 18.82万 - 项目类别:
Generation of a mouse model of episodic ataxia type 2 (EA2)
2 型发作性共济失调 (EA2) 小鼠模型的生成
- 批准号:
7313608 - 财政年份:2007
- 资助金额:
$ 18.82万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 18.82万 - 项目类别:
Research Grant